Last updated on March 2019

Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)

Brief description of study

To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of schizophrenia

Clinical Study Identifier: NCT02970292

Contact Investigators or Research Sites near you

Start Over

Ken Smith

Tserova Koria, Bulgaria
  Connect »

Ken Smith

Veliko Tarnovo, Bulgaria
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.